Molecular Carcinogenesis · 2007 · 87 citations · 27 references
MedicineImmunologyPathologyCancer ImmunologyImmunopathologyInnate ImmunityCervical CancerCervical Intraepithelial NeoplasiaCervical LesionsCervical PathologyInnate Immune ReceptorsToll-like ReceptorsCervical Squamous LesionsImmunohistochemical BiomarkersImmunohistochemical DetectionImmunohistochemical MarkersImmunohistochemical StainingToll-like Receptor SignalingToll-like Receptor-mediated Innate Immune ResponseToll-like Receptors In Cancer
Toll-like receptors (TLRs) recognize pathogen-associated molecular patterns (PAMPs) and enable innate immune responses. Although TLR9 has been previously considered to be expressed only in immune cells, there is now increasing evidence that TLR9 expression is present in nonimmune cells as well. In this study, we undertook to determine whether TLR9 expression was associated with disease progression in cervical neoplasia. TLR9 expression was evaluated by immunohistochemistry in 55 formalin-fixed paraffin-embedded cervical tissues; nine normal cervical specimens, 10 low-grade cervical intraepithelial neoplasias (CINs), 12 high-grade CINs, and 24 invasive squamous cell carcinomas (ISCCs). In addition, TLR9 expression was evaluated, at the RNA level, in fresh frozen cervical carcinoma tissues by real-time quantitative RT-PCR. Immunohistochemical staining showed that TLR9 expression was undetectable (55.6%) or weak (44.4%) in normal cervical squamous epithelial tissues, however, variable staining was observed in the basal layer of all normal endocervical glands. TLR9 expression, which was mainly observed as cytoplasmic staining, gradually increased in accordance with the histopathological grade in the following order: low-grade CIN<high-grade CIN<ISCC (P<0.001), and in particular, was moderate to strong in 70% of ISCC cases. Furthermore, real-time quantitative RT-PCR revealed that TLR9 expression, in tumors, was significantly enhanced compared to normal cervical tissues (P=0.012). These results suggest that TLR9 may play a significant role in tumor progression of cervical neoplasia and may represent a useful marker for malignant transformation of cervical squamous cells.
27
Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in <i>Tlr4</i> Gene
Alexander Poltorak, Xiaolong He, Irina Smirnova et al. · Science · 1998 · 7.6K citations
A Toll-like receptor recognizes bacterial DNA
Hiroaki Hemmi, Osamu Takeuchi, Taro Kawai et al. · Nature · 2000 · 6.4K citations
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Lena Alexopoulou, Agnieszka Czopik Holt, Ruslan Medzhitov et al. · Nature · 2001 · 6.1K citations
The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5
Fumitaka Hayashi, Kelly D. Smith, Adrian Ozinsky et al. · Nature · 2001 · 3.6K citations
Cell Activation and Apoptosis by Bacterial Lipoproteins Through Toll-like Receptor-2
Antonios O. Aliprantis, Ruey‐Bing Yang, Melanie R. Mark et al. · Science · 1999 · 1.5K citations